Clinical Trial Update: Safety and Efficacy of HO/02/02 20µg vs. SoC (Aloe Vera) to Reduce Radiation Dermatitis [EARLY_Phase 1]

View source ↗

Summary

An EARLY Phase 1 trial evaluates the safety and preliminary efficacy of HO/02/02 20µg versus Aloe Vera standard of care for reducing radiation dermatitis in bre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aloe vera (Aloe vera)
• HO/02/02 20µg (HO/02/02 20µg)

Snippet

Sponsor: HealOr | Conditions: Breast Cancer | EARLY_Phase 1 | Status: UNKNOWN